Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

About Jiatai New Century

Jiatai focuses on early and mid-term project investment in the global biomedical field, focusing on discovering outstanding entrepreneurial teams in the field of life sciences.

Jiatai New Century Headquarter Location

Nanchang, Jiangxi,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Jiatai New Century Investments

2 Investments

Jiatai New Century has made 2 investments. Their latest investment was in HighTide as part of their Series B - II on December 12, 2020.

CBI Logo

Jiatai New Century Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/8/2020

Series B - II

HighTide

Yes

4

3/12/2020

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/8/2020

3/12/2020

Round

Series B - II

Series B - II

Company

HighTide

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

4

10

Jiatai New Century Portfolio Exits

1 Portfolio Exit

Jiatai New Century has 1 portfolio exit. Their latest portfolio exit was Harbour BioMed on December 10, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/10/2020

IPO

2

Date

12/10/2020

Exit

IPO

Companies

Valuation

Acquirer

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.